Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresected Stage IIIB to IVM1c Melanoma”

5 trials

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT02366195
What this trial is testing

Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Unresected Stage IIIb to IVM1c Melanoma
Amgen 112
Not applicableNo Longer AvailableNCT02147951
What this trial is testing

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

Who this might be right for
Unresected Stage IIIb to IVM1c Melanoma
Amgen
Testing effectiveness (Phase 2)Study completedNCT02014441
What this trial is testing

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Who this might be right for
Melanoma
Amgen 61
Not applicableNo Longer AvailableNCT02297529
What this trial is testing

Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma

Who this might be right for
Unresected Stage IIIB to IVM1c Melanoma
Amgen
Large-scale testing (Phase 3)Ended earlyNCT02263508
What this trial is testing

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

Who this might be right for
Melanoma
Amgen 713

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation